Application 077131

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 1.5MG BASE	No	No
002	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 3MG BASE	No	No
003	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 4.5MG BASE	No	No
004	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	CAPSULE;ORAL	EQ 6MG BASE	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
62756-145	Rivastigmine Tartrate	Rivastigmine Tartrate	Sun Pharmaceutical Industries, Inc.	ANDA	Current
62756-146	Rivastigmine Tartrate	Rivastigmine Tartrate	Sun Pharmaceutical Industries, Inc.	ANDA	Current
62756-147	Rivastigmine Tartrate	Rivastigmine Tartrate	Sun Pharmaceutical Industries, Inc.	ANDA	Current
62756-148	Rivastigmine Tartrate	Rivastigmine Tartrate	Sun Pharmaceutical Industries, Inc.	ANDA	Current
68084-550	Rivastigmine Tartrate	Rivastigmine Tartrate	American Health Packaging	ANDA	Current
68084-550	Rivastigmine Tartrate	Rivastigmine Tartrate	American Health Packaging	ANDA	Current
68084-550	Rivastigmine Tartrate	Rivastigmine Tartrate	American Health Packaging	ANDA	Current
68151-4134	Rivastigmine Tartrate	Rivastigmine Tartrate	Carilion Materials Management	ANDA	Current

Document, Submission type, Date table
Document	Submission type	Date
31200	ORIG	2007-10-25